Dr Peter Glidden speaks about Dr Wallach who sued the FDA to secure something called ‘qualified health claim’
Following the remand, the parties entered into negotiations that have culminated in a breakthrough, permitting use of the following qualified health claims on selenium-containing dietary supplements. Each claim bears a succinct and accurate qualification, consistent with the Court’s requirements. The qualifications are the shortest FDA has ever permitted for use with qualified health claims. The selenium qualified health claims may be used by any company that sells selenium containing dietary supplements in the United States. “This settlement permits information about the potential of selenium to reduce site specific cancers to reach consumers. It will help guide consumer choice in health enhancing ways,” Jonathan Emord, counsel for the plaintiffs, said. “I hope this resolution becomes a model for FDA in subsequent qualified claims cases,” he said. “Compliance with the First Amendment requirement in Pearson v. Shalala that FDA favor disclosure of nutrient-disease information over its suppression is long overdue.” The following claims may be used on labels and in labeling of selenium-containing dietary supplements effective immediately: EMORD & ASSOCIATES, P.C. (202) 466-6937/FAX (202) 466-6938 PAGE 2 OF 2
Prostate Cancer Claim “Selenium may reduce the risk of prostate cancer. Scientific evidence concerning this claim is inconclusive. Based on its review, FDA does not agree that selenium may reduce the risk of prostate cancer.”
Colon Cancer Claim “Selenium may reduce the risk of colon cancer. Scientific evidence concerning this claim is inconclusive. Based on its review, FDA does not agree that selenium may reduce the risk of colon cancer.”
Certain Cancers Claim and Anticarcinogenic Effects Claim “Selenium may reduce the risk of bladder, colon, prostate, and thyroid cancers. Scientific evidence concerning this claim is inconclusive. Based on its review, FDA does not agree that selenium may reduce the risk of these cancers.” The parties continue to discuss means to resolve disagreements concerning selenium-lung and respiratory tract cancer and selenium-digestive tract cancer claims.
http://www.eagle-min.com/faq/faq93.htm
SELENIUM, HEPATITIS B, AND LIVER CANCER High rates of hepatitis B virus infection and primary liver cancer are present in the Qidong county of China. Surveys demonstrated an inverse association between selenium level and cancer incidence, as well as hepatitis B virus infection.SELENIUM, HEPATITIS B, AND LIVER CANCER A four-year animal study showed that dietary supplement of selenium reduced the hepatitis B infection by 77.2% and liver precancerous lesion by 75.8% of ducks, caused by exposure to natural environmental factors.SELENIUM, HEPATITIS B, AND LIVER CANCER
SELENIUM, HEPATITIS B, AND LIVER CANCER A study was undertaken among the general population of 130,471.( https://pubmed.ncbi.nlm.nih.gov/9152515/ ) Individuals in five townships were involved for observation of the preventive effect of selenium. The 8-year follow-up data showed reduced liver cancer incidence by 35.1% in table salt fortified with selenium vs the non supplemented population. On the withdrawal of selenium from the treated group, liver cancer rates began to increase. However, the inhibitory response to hepatitis B was sustained during the 3-yr after the treatment was stopped.SELENIUM, HEPATITIS B, AND LIVER CANCER
SELENIUM, HEPATITIS B, AND LIVER CANCER In another study by the authors 226 hepatitis B positive persons provided either 200 micrograms of a selenium tablet or an identical placebo daily for 4 yr showed that 7 of 113 subjects were diagnosed as having liver cancer in the placebo group, whereas no incidence of liver cancer was found in 113 subjects supplemented with selenium. Again on cessation of treatment, liver cancer developed at a rate comparable to that in the control group, demonstrating that a continuous intake of selenium is essential to sustain its effect.SELENIUM, HEPATITIS B, AND LIVER CANCER
--------------------- Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Yu SY, Zhu YJ, Li WG Bio Trace Elem Res 1997 Jan;56(1):117-124